{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T19:37:53Z","timestamp":1793475473586,"version":"4.5.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:00:00Z","timestamp":1542672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00415-018-9119-x","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T09:56:16Z","timestamp":1542707776000},"page":"2897-2906","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Quality of life in idiopathic dystonia: a systematic review"],"prefix":"10.1007","volume":"266","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8451-7127","authenticated-orcid":false,"given":"Ayesha","family":"Girach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Vinagre Aragon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Zis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"issue":"Supplement","key":"9119_CR1","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.4103\/0028-3886.226439","volume":"66","author":"A Batla","year":"2018","unstructured":"Batla A (2018) Dystonia: a review. Neurol India 66(Supplement):S48\u2013S58","journal-title":"Neurol India"},{"issue":"Suppl 1","key":"9119_CR2","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.parkreldis.2017.06.025","volume":"46","author":"CL Comella","year":"2018","unstructured":"Comella CL. Dystonia (2018) Then and now. Parkinsonism Relat Disord 46(Suppl 1):S66\u2013S69","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"9119_CR3","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/jnnp.72.5.608","volume":"72","author":"Y Ben-Shlomo","year":"2002","unstructured":"Ben-Shlomo Y, Camfield L, Warner T (2002) What are the determinants of quality of life in people with cervical dystonia? J Neurol Neurosurg Psychiatry 72(5):608\u2013614","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"9119_CR4","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/mds.10127","volume":"17","author":"L Camfield","year":"2002","unstructured":"Camfield L, Ben-Shlomo Y, Warner TT (2002) Impact of cervical dystonia on quality of life. Mov Disord 17(4):838\u2013841","journal-title":"Mov Disord"},{"key":"9119_CR5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.parkreldis.2016.08.014","volume":"32","author":"J Dool van den","year":"2016","unstructured":"van den Dool J, Tijssen MAJ, Koelman JHTM, Engelbert RHH, Visser B (2016) Determinants of disability in cervical dystonia. Parkinsonism Relat Disord 32:48\u201353","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"9119_CR6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/mds.22983","volume":"25","author":"G Fabbrini","year":"2010","unstructured":"Fabbrini G, Berardelli I, Moretti G, Pasquini M, Bloise M, Colosimo C et al (2010) Psychiatric disorders in adult-onset focal dystonia: a case\u2013control study. Mov Disord 25(4):459\u2013465","journal-title":"Mov Disord"},{"issue":"7","key":"9119_CR7","first-page":"e1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group TP (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med Public Library of Science 6(7):e1000097","journal-title":"PLOS Med Public Library of Science"},{"issue":"5","key":"9119_CR8","doi-asserted-by":"crossref","first-page":"749 LP-753","DOI":"10.1136\/jnnp.2003.013441","volume":"75","author":"J M\u00fcller","year":"2004","unstructured":"M\u00fcller J, Wissel J, Kemmler G, Voller B, Bodner T, Schneider A et al (2004) Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument. J Neurol Neurosurg Psychiatry 75(5):749 LP-753","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"9119_CR9","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1749-4486.2010.02194.x","volume":"35","author":"RI Merz","year":"2010","unstructured":"Merz RI, Deakin J, Hawthorne MR (2010) Oromandibular dystonia questionnaire (OMDQ-25): a valid and reliable instrument for measuring health-related quality of life. Clin Otolaryngol 35(5):390\u2013396","journal-title":"Clin Otolaryngol"},{"issue":"7","key":"9119_CR10","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s00415-014-7343-6","volume":"261","author":"PD Charles","year":"2014","unstructured":"Charles PD, Adler CH, Stacy M, Comella C, Jankovic J, Manack Adams A et al (2014) Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy). J Neurol 261(7):1309\u20131319","journal-title":"J Neurol"},{"issue":"7","key":"9119_CR11","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1007\/s00415-002-0733-1","volume":"249","author":"J Muller","year":"2002","unstructured":"Muller J, Kemmler G, Wissel J, Schneider A, Voller B, Grossmann J et al (2002) The impact of blepharospasm and cervical dystonia on health-related quality of life and depression. J Neurol 249(7):842\u2013846","journal-title":"J Neurol"},{"issue":"2","key":"9119_CR12","first-page":"95","volume":"22","author":"J Slawek","year":"2007","unstructured":"Slawek J, Friedman A, Potulska A, Krystkowiak P, Gervais C, Banach M et al (2007) Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections. Funct Neurol 22(2):95\u2013100","journal-title":"Funct Neurol"},{"issue":"10","key":"9119_CR13","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1468-1331.2007.01922.x","volume":"14","author":"IM Skogseid","year":"2007","unstructured":"Skogseid IM, Malt UF, Roislien J, Kerty E (2007) Determinants and status of quality of life after long-term botulinum toxin therapy for cervical dystonia. Eur J Neurol 14(10):1129\u20131137","journal-title":"Eur J Neurol"},{"issue":"6","key":"9119_CR14","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1590\/S0004-282X2011000700010","volume":"69","author":"MR Queiroz","year":"2011","unstructured":"Queiroz MR, Chien HF, Barbosa ER (2011) Quality of life in individuals with cervical dystonia before botulinum toxin injection in a Brazilian tertiary care hospital. Arq Neuropsiquiatr 69(6):900\u2013904","journal-title":"Arq Neuropsiquiatr"},{"issue":"3","key":"9119_CR15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/mds.21234","volume":"22","author":"D Page","year":"2007","unstructured":"Page D, Butler A, Jahanshahi M (2007) Quality of life in focal, segmental, and generalized dystonia. Mov Disord 22(3):341\u2013347","journal-title":"Mov Disord"},{"issue":"6","key":"9119_CR16","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1600-0404.2008.01111.x","volume":"119","author":"L Zetterberg","year":"2009","unstructured":"Zetterberg L, Aquilonius S-M, Lindmark B (2009) Impact of dystonia on quality of life and health in a Swedish population. Acta Neurol Scand 119(6):376\u2013382","journal-title":"Acta Neurol Scand"},{"issue":"7","key":"9119_CR17","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/mds.21486","volume":"22","author":"VK Lim","year":"2007","unstructured":"Lim VK (2007) Health related quality of life in patients with dystonia and their caregivers in New Zealand and Australia. Mov Disord 22(7):998\u20131003","journal-title":"Mov Disord"},{"issue":"2","key":"9119_CR18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.clineuro.2008.09.023","volume":"111","author":"T Pekmezovic","year":"2009","unstructured":"Pekmezovic T, Svetel M, Ivanovic N, Dragasevic N, Petrovic I, Tepavcevic DK et al (2009) Quality of life in patients with focal dystonia. Clin Neurol Neurosurg 111(2):161\u2013164","journal-title":"Clin Neurol Neurosurg"},{"issue":"6","key":"9119_CR19","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/s00415-009-5060-3","volume":"256","author":"A Soeder","year":"2009","unstructured":"Soeder A, Kluger BM, Okun MS, Garvan CW, Soeder T, Jacobson CE et al (2009) Mood and energy determinants of quality of life in dystonia. J Neurol 256(6):996\u20131001","journal-title":"J Neurol"},{"issue":"11","key":"9119_CR20","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1007\/s00415-008-0020-x","volume":"255","author":"L Lewis","year":"2008","unstructured":"Lewis L, Butler A, Jahanshahi M (2008) Depression in focal, segmental and generalized dystonia. J Neurol 255(11):1750\u20131755","journal-title":"J Neurol"},{"issue":"4","key":"9119_CR21","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s13760-016-0634-1","volume":"116","author":"S Tomic","year":"2016","unstructured":"Tomic S, Petkovic I, Pucic T, Resan B, Juric S, Rotim T (2016) Cervical dystonia and quality of life. Acta Neurol 116(4):589\u2013592","journal-title":"Acta Neurol"},{"issue":"7","key":"9119_CR22","doi-asserted-by":"crossref","first-page":"595 LP-602","DOI":"10.1136\/jnnp-2016-315461","volume":"88","author":"BD Berman","year":"2017","unstructured":"Berman BD, Junker J, Shelton E, Sillau SH, Jinnah HA, Perlmutter JS et al (2017) Psychiatric associations of adult-onset focal dystonia phenotypes. J Neurol Neurosurg Psychiatry 88(7):595 LP-602","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"9119_CR23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1590\/0004-282X20140044","volume":"72","author":"RW Werle","year":"2014","unstructured":"Werle RW, Takeda SYM, Zonta MB, Guimaraes ATB, Teive HAG (2014) The physical, social and emotional aspects are the most affected in the quality of life of the patients with cervical dystonia. Arq Neuropsiquiatr 72(6):405\u2013410","journal-title":"Arq Neuropsiquiatr"},{"issue":"10","key":"9119_CR24","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3109\/00207454.2015.1085035","volume":"126","author":"A Wagle Shukla","year":"2016","unstructured":"Wagle Shukla A, Brown R, Heese K, Jones J, Rodriguez RL, Malaty IM et al (2016) High rates of fatigue and sleep disturbances in dystonia. Int J Neurosci 126(10):928\u2013935","journal-title":"Int J Neurosci"},{"issue":"4","key":"9119_CR25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.parkreldis.2014.01.004","volume":"20","author":"SR Eichenseer","year":"2014","unstructured":"Eichenseer SR, Stebbins GT, Comella CL (2014) Beyond a motor disorder: a prospective evaluation of sleep quality in cervical dystonia. Parkinsonism Relat Disord 20(4):405\u2013408","journal-title":"Parkinsonism Relat Disord"},{"issue":"10","key":"9119_CR26","doi-asserted-by":"crossref","first-page":"e005150","DOI":"10.1136\/bmjopen-2014-005150","volume":"4","author":"M Mordin","year":"2014","unstructured":"Mordin M, Masaquel C, Abbott C, Copley-Merriman C (2014) Factors affecting the health-related quality of life of patients with cervical dystonia and impact of treatment with abobotulinumtoxinA (Dysport): results from a randomised, double-blind, placebo-controlled study. BMJ Open 4(10):e005150","journal-title":"BMJ Open"},{"issue":"1","key":"9119_CR27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/WNF.0b013e3181c46f48","volume":"33","author":"EMAB Quagliato","year":"2010","unstructured":"Quagliato EMAB, Carelli EF, Viana MA (2010) A prospective, randomized, double-blind study comparing the efficacy and safety of type a botulinum toxins botox and prosigne in the treatment of cervical dystonia. Clin Neuropharmacol 33(1):22\u201326","journal-title":"Clin Neuropharmacol"},{"issue":"2","key":"9119_CR28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.71.2.193","volume":"71","author":"R Hilker","year":"2001","unstructured":"Hilker R, Schischniaschvili M, Ghaemi M, Jacobs A, Rudolf J (2001) Health related quality of life is improved by botulinum neurotoxin type A in long term treated patients with focal dystonia. J Neurol Neurosurg Psychiatry 71(2):193\u2013199","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"9119_CR29","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1212\/WNL.50.5.1461","volume":"50","author":"JW Brans","year":"1998","unstructured":"Brans JW, Lindeboom R, Aramideh M, Speelman JD (1998) Long-term effect of botulinum toxin on impairment and functional health in cervical dystonia. Neurology 50(5):1461\u20131463","journal-title":"Neurology"},{"issue":"3","key":"9119_CR30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3111\/13696998.2011.653726","volume":"15","author":"KD Sethi","year":"2012","unstructured":"Sethi KD, Rodriguez R, Olayinka B (2012) Satisfaction with botulinum toxin treatment: a cross-sectional survey of patients with cervical dystonia. J Med Econ 15(3):419\u2013423","journal-title":"J Med Econ"},{"issue":"11","key":"9119_CR31","first-page":"1989","volume":"19","author":"L Huang","year":"2015","unstructured":"Huang L, Chen H-X, Ding X-D, Xiao H-Q, Wang W, Wang H (2015) Efficacy analysis of ultrasound-guided local injection of botulinum toxin type A treatment with orthopedic joint brace in patients with cervical dystonia. Eur Rev Med Pharmacol Sci 19(11):1989\u20131993","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"9119_CR32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2165\/00126839-200809030-00002","volume":"9","author":"AJ Dowson","year":"2008","unstructured":"Dowson AJ, Kilminster SG, Salt R (2008) Clinical profile of botulinum toxin A in patients with chronic headaches and cervical dystonia: a prospective, open-label, longitudinal study conducted in a naturalistic clinical practice setting. Drugs R D 9(3):147\u2013158","journal-title":"Drugs R D"},{"key":"9119_CR33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.toxicon.2017.09.004","volume":"147","author":"HA Jinnah","year":"2018","unstructured":"Jinnah HA, Comella CL, Perlmutter J, Lungu C, Hallett M (2018) Longitudinal studies of botulinum toxin in cervical dystonia: why do patients discontinue therapy? Toxicon 147:89\u201395","journal-title":"Toxicon"},{"issue":"3","key":"9119_CR34","first-page":"187","volume":"27","author":"MAR Queiroz","year":"2012","unstructured":"Queiroz MAR, Chien HF, Sekeff-Sallem FA, Barbosa ER (2012) Physical therapy program for cervical dystonia: a study of 20 cases. Funct Neurol 27(3):187\u2013192","journal-title":"Funct Neurol"},{"issue":"4","key":"9119_CR35","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/09593980701884816","volume":"24","author":"L Zetterberg","year":"2008","unstructured":"Zetterberg L, Halvorsen K, Farnstrand C, Aquilonius S-M, Lindmark B (2008) Physiotherapy in cervical dystonia: six experimental single-case studies. Physiother Theory Pract 24(4):275\u2013290","journal-title":"Physiother Theory Pract"},{"issue":"12","key":"9119_CR36","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1474-4422(12)70257-0","volume":"11","author":"J Volkmann","year":"2012","unstructured":"Volkmann J, Wolters A, Kupsch A, M\u00fcller J, K\u00fchn AA, Schneider G-H et al (2012) Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial. Lancet Neurol 11(12):1029\u20131038","journal-title":"Lancet Neurol"},{"issue":"12","key":"9119_CR37","doi-asserted-by":"crossref","first-page":"1383 LP-1389","DOI":"10.1136\/jnnp.2010.207993","volume":"81","author":"C Andrews","year":"2010","unstructured":"Andrews C, Aviles-Olmos I, Hariz M, Foltynie T (2010) Which patients with dystonia benefit from deep brain stimulation? A metaregression of individual patient outcomes. J Neurol Neurosurg Psychiatry 81(12):1383 LP-1389","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"9119_CR38","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3171\/JNS\/2008\/109\/9\/0405","volume":"109","author":"TE Pretto","year":"2008","unstructured":"Pretto TE, Dalvi A, Kang UJ, Penn RD (2008) A prospective blinded evaluation of deep brain stimulation for the treatment of secondary dystonia and primary torticollis syndromes. J Neurosurg 109(3):405\u2013409","journal-title":"J Neurosurg"},{"issue":"1","key":"9119_CR39","first-page":"E5","volume":"17","author":"ZH Kiss","year":"2004","unstructured":"Kiss ZH, Doig K, Eliasziw M, Ranawaya R, Suchowersky O (2004) The Canadian multicenter trial of pallidal deep brain stimulation for cervical dystonia: preliminary results in three patients. Neurosurg Focus 17(1):E5","journal-title":"Neurosurg Focus"},{"key":"9119_CR40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.wneu.2017.03.091","volume":"103","author":"DE Sakas","year":"2017","unstructured":"Sakas DE, Leonardos A, Boviatsis E, Gatzonis S, Panourias I, Stathis P et al (2017) Constant-current deep brain stimulation of the globus pallidus internus in the treatment of primary dystonia by a novel 8-contact (Octrode) lead. World Neurosurg 103:45\u201356","journal-title":"World Neurosurg"},{"issue":"10","key":"9119_CR41","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1212\/WNL.0b013e31820f2e4f","volume":"76","author":"JL Ostrem","year":"2011","unstructured":"Ostrem JL, Racine CA, Glass GA, Grace JK, Volz MM, Heath SL et al (2011) Subthalamic nucleus deep brain stimulation in primary cervical dystonia. Neurology 76(10):870\u2013878","journal-title":"Neurology"},{"issue":"1","key":"9119_CR42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3171\/JNS-07\/07\/0029","volume":"107","author":"G Kleiner-Fisman","year":"2007","unstructured":"Kleiner-Fisman G, Liang GSL, Moberg PJ, Ruocco AC, Hurtig HI, Baltuch GH et al (2007) Subthalamic nucleus deep brain stimulation for severe idiopathic dystonia: impact on severity, neuropsychological status, and quality of life. J Neurosurg 107(1):29\u201336","journal-title":"J Neurosurg"},{"issue":"1","key":"9119_CR43","doi-asserted-by":"crossref","first-page":"25 LP-35","DOI":"10.1212\/WNL.0000000000003451","volume":"88","author":"JL Ostrem","year":"2017","unstructured":"Ostrem JL, San Luciano M, Dodenhoff KA, Ziman N, Markun LC, Racine CA et al (2017) Subthalamic nucleus deep brain stimulation in isolated dystonia. Neurology 88(1):25 LP-35","journal-title":"Neurology"},{"issue":"6","key":"9119_CR44","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3171\/2013.8.JNS13844","volume":"119","author":"L Schjerling","year":"2013","unstructured":"Schjerling L, Hjermind LE, Jespersen B, Madsen FF, Brennum J, Jensen SR et al (2013) A randomized double-blind crossover trial comparing subthalamic and pallidal deep brain stimulation for dystonia. J Neurosurg 119(6):1537\u20131545","journal-title":"J Neurosurg"},{"issue":"4","key":"9119_CR45","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/brain\/124.4.769","volume":"124","author":"A M\u00fcnchau","year":"2001","unstructured":"M\u00fcnchau A, Palmer JD, Dressler D, O\u2019Sullivan JD, Tsang KL, Jahanshahi M et al (2001) Prospective study of selective peripheral denervation for botulinum-toxin resistant patients with cervical dystonia. Brain;124(4):769\u201383","journal-title":"Brain"},{"issue":"12","key":"9119_CR46","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1136\/jnnp-2014-307959","volume":"86","author":"AT Bergenheim","year":"2015","unstructured":"Bergenheim AT, Nordh E, Larsson E, Hariz MI (2015) Selective peripheral denervation for cervical dystonia: long-term follow-up. J Neurol Neurosurg Psychiatry 86(12):1307\u20131313","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"9119_CR47","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1468-1331.2009.02944.x","volume":"17","author":"S-S Zhang","year":"2010","unstructured":"Zhang S-S, Fang D-F, Hu X-H, Burgunder J-M, Chen X-P, Zhang Y-W et al (2010) Clinical feature and DYT1 mutation screening in primary dystonia patients from South-West China. Eur J Neurol 17(6):846\u2013851","journal-title":"Eur J Neurol"},{"issue":"8","key":"9119_CR48","doi-asserted-by":"crossref","first-page":"e0160867","DOI":"10.1371\/journal.pone.0160867","volume":"11","author":"J Yang","year":"2016","unstructured":"Yang J, Song W, Wei Q, Ou R, Cao B, Liu W et al (2016) Screening for Cognitive Impairments in Primary Blepharospasm. PLoS One 11(8):e0160867","journal-title":"PLoS One"},{"issue":"9","key":"9119_CR49","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s11136-011-9890-y","volume":"20","author":"S Setthawatcharawanich","year":"2011","unstructured":"Setthawatcharawanich S, Sathirapanya P, Limapichat K, Phabphal K (2011) Factors associated with quality of life in hemifacial spasm and blepharospasm during long-term treatment with botulinum toxin. Qual Life Res 20(9):1519\u20131523","journal-title":"Qual Life Res"},{"issue":"1","key":"9119_CR50","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1001\/archopht.124.1.116","volume":"124","author":"TA Hall","year":"2006","unstructured":"Hall TA, McGwin GJ, Searcey K, Xie A, Hupp SL, Owsley C et al (2006) Health-related quality of life and psychosocial characteristics of patients with benign essential blepharospasm. Arch Ophthalmol (Chicago, Ill 1960) 124(1):116\u2013119","journal-title":"Arch Ophthalmol (Chicago, Ill 1960)"},{"issue":"1","key":"9119_CR51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1034\/j.1600-0404.2001.00109.x","volume":"103","author":"O Tucha","year":"2001","unstructured":"Tucha O, Naumann M, Berg D, Alders GL, Lange KW (2001) Quality of life in patients with blepharospasm. Acta Neurol Scand 103(1):49\u201352","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"9119_CR52","first-page":"29","volume":"37","author":"D Biuk","year":"2013","unstructured":"Biuk D, Karin AA, Matic S, Barac J, Benasic T, Stiglmayer N (2013) Quality of life in patients with blepharospasm. Coll Antropol 37(1):29\u201333","journal-title":"Coll Antropol"},{"issue":"8","key":"9119_CR53","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.parkreldis.2007.03.006","volume":"13","author":"S Ochudlo","year":"2007","unstructured":"Ochudlo S, Bryniarski P, Opala G (2007) Botulinum toxin improves the quality of life and reduces the intensification of depressive symptoms in patients with blepharospasm. Parkinsonism Relat Disord 13(8):505\u2013508","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"9119_CR54","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/01676830490506041","volume":"23","author":"K MacAndie","year":"2004","unstructured":"MacAndie K, Kemp E (2004) Impact on quality of life of botulinum toxin treatments for essential blepharospasm. Orbit England 23(4):207\u2013210","journal-title":"Orbit England"},{"issue":"6","key":"9119_CR55","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s10384-016-0469-6","volume":"60","author":"Y Isshiki","year":"2016","unstructured":"Isshiki Y, Ishikawa H, Mimura O (2016) Changes in ocular higher-order aberrations following botulinum toxin treatment in patients with blepharospasm. Jpn J Ophthalmol 60(6):486\u2013491","journal-title":"Jpn J Ophthalmol"},{"issue":"3","key":"9119_CR56","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/IOP.0b013e3182805a2a","volume":"29","author":"RMH Lee","year":"2013","unstructured":"Lee RMH, Chowdhury HR, Hyer JN, Smith HB, Jones CA (2013) Patient-reported benefit from botulinum toxin treatment for essential blepharospasm: using 2 assessment scales. Ophthal Plast Reconstr Surg 29(3):196\u2013197","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"9","key":"9119_CR57","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.ophtha.2006.03.055","volume":"113","author":"RL Levy","year":"2006","unstructured":"Levy RL, Berman D, Parikh M, Miller NR (2006) Supramaximal doses of botulinum toxin for refractory blepharospasm. Ophthalmology 113(9):1665\u20131668","journal-title":"Ophthalmology"},{"issue":"1","key":"9119_CR58","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1600-0404.2004.00357.x","volume":"111","author":"J Reimer","year":"2005","unstructured":"Reimer J, Gilg K, Karow A, Esser J, Franke GH (2005) Health-related quality of life in blepharospasm or hemifacial spasm. Acta Neurol Scand 111(1):64\u201370","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"9119_CR59","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s13760-014-0285-z","volume":"114","author":"H Streitova","year":"2014","unstructured":"Streitova H, Bares M (2014) Long-term therapy of benign essential blepharospasm and facial hemispasm with botulinum toxin A: retrospective assessment of the clinical and quality of life impact in patients treated for more than 15 years. Acta Neurol Belg 114(4):285\u2013291","journal-title":"Acta Neurol Belg"},{"issue":"11","key":"9119_CR60","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jamaophthalmol.2016.3277","volume":"134","author":"K CS","year":"2016","unstructured":"CS K, EJ C, Salam T, Hersh D, Ortiz-Perez S, Ezra D (2016) Use of alleviating maneuvers for periocular facial dystonias. JAMA Ophthalmol; 134(11):1247\u201352","journal-title":"JAMA Ophthalmol"},{"issue":"9","key":"9119_CR61","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/archotol.127.9.1083","volume":"127","author":"MS Benninger","year":"2001","unstructured":"Benninger MS, Gardner G, Grywalski C (2001) Outcomes of botulinum toxin treatment for patients with spasmodic dysphonia. Arch Otolaryngol Head Neck Surg 127(9):1083\u20131085","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"4","key":"9119_CR62","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0892-1997(01)00060-1","volume":"15","author":"ND Hogikyan","year":"2001","unstructured":"Hogikyan ND, Wodchis WP, Spak C, Kileny PR (2001) Longitudinal effects of botulinum toxin injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia. J Voice 15(4):576\u2013586","journal-title":"J Voice"},{"issue":"1","key":"9119_CR63","first-page":"39","volume":"131","author":"ACC Gama","year":"2010","unstructured":"Gama ACC, Menezes LN, Maia AA, Rezende Neto AL, Oliveira JB (2010) Voice related quality of life after botulinum toxin injection for spasmodic dysphonia. Rev Laryngol Otol Rhinol (Bord) 131(1):39\u201344","journal-title":"Rev Laryngol Otol Rhinol (Bord)"},{"issue":"5","key":"9119_CR64","doi-asserted-by":"crossref","first-page":"666.e7","DOI":"10.1016\/j.jvoice.2011.07.009","volume":"26","author":"DH Tsuji","year":"2012","unstructured":"Tsuji DH, Takahashi MT, Imamura R, Hachiya A, Sennes LU (2012) Endoscopic laser thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia: a pilot study on long-term outcome on voice quality. J Voice 26(5):666.e7\u2013666.e12","journal-title":"J Voice"},{"issue":"4","key":"9119_CR65","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/archotol.127.4.389","volume":"127","author":"N Bhattacharyya","year":"2001","unstructured":"Bhattacharyya N, Tarsy D (2001) Impact on quality of life of botulinum toxin treatments for spasmodic dysphonia and oromandibular dystonia. Arch Otolaryngol Head Neck Surg 127(4):389\u2013392","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"5","key":"9119_CR66","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/occmed\/kqv038","volume":"65","author":"A Lee","year":"2015","unstructured":"Lee A, Eich C, Ioannou CI, Altenm\u00fcller E (2015) Life satisfaction of musicians with focal dystonia. Occup Med (Chic Ill);65(5):380\u2013385","journal-title":"Occup Med (Chic Ill)"},{"issue":"9","key":"9119_CR67","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1007\/s00415-016-8185-1","volume":"263","author":"L Nastasi","year":"2016","unstructured":"Nastasi L, Mostile G, Nicoletti A, Zappia M, Reggio E, Catania S (2016) Effect of botulinum toxin treatment on quality of life in patients with isolated lingual dystonia and oromandibular dystonia affecting the tongue. J Neurol 263(9):1702\u20131708","journal-title":"J Neurol"},{"issue":"2","key":"9119_CR68","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1177\/014556131109000210","volume":"90","author":"SJ Charous","year":"2011","unstructured":"Charous SJ, Comella CL, Fan W (2011) Jaw-opening dystonia: Quality of life after botulinum toxin injections. Ear Nose Throat J 90(2):E9","journal-title":"Ear Nose Throat J"},{"issue":"9","key":"9119_CR69","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2298\/VSP1209759B","volume":"69","author":"N Basurovic","year":"2012","unstructured":"Basurovic N, Svetel M, Pekmezovic T, Kostic VS (2012) Evaluation of the quality of life in patients with segmental dystonia. Vojnosanit Pregl 69(9):759\u2013764","journal-title":"Vojnosanit Pregl"},{"issue":"2","key":"9119_CR70","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s00415-008-0614-3","volume":"255","author":"C Blahak","year":"2008","unstructured":"Blahak C, Wohrle JC, Capelle HH, Bazner H, Grips E, Weigel R et al (2008) Health-related quality of life in segmental dystonia is improved by bilateral pallidal stimulation. J Neurol 255(2):178\u2013182","journal-title":"J Neurol"},{"issue":"10","key":"9119_CR71","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00415-003-0179-0","volume":"250","author":"A Kupsch","year":"2003","unstructured":"Kupsch A, Klaffke S, Kuhn AA, Meissner W, Arnold G, Schneider GH et al (2003) The effects of frequency in pallidal deep brain stimulation for primary dystonia. J Neurol 250(10):1201\u20131205","journal-title":"J Neurol"},{"issue":"1","key":"9119_CR72","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/jnnp.2009.174342","volume":"81","author":"F Valldeoriola","year":"2010","unstructured":"Valldeoriola F, Regidor I, Minguez-Castellanos A, Lezcano E, Garcia-Ruiz P, Rojo A et al (2010) Efficacy and safety of pallidal stimulation in primary dystonia: results of the Spanish multicentric study. J Neurol Neurosurg Psychiatry 81(1):65\u201369","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"9119_CR73","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/mds.21783","volume":"23","author":"J Mueller","year":"2008","unstructured":"Mueller J, Skogseid IM, Benecke R, Kupsch A, Trottenberg T, Poewe W et al (2008) Pallidal deep brain stimulation improves quality of life in segmental and generalized dystonia: results from a prospective, randomized sham-controlled trial. Mov Disord 23(1):131\u2013134","journal-title":"Mov Disord"},{"issue":"11","key":"9119_CR74","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.parkreldis.2014.09.005","volume":"20","author":"AG Shaikh","year":"2014","unstructured":"Shaikh AG, Mewes K, Jinnah HA, DeLong MR, Gross RE, Triche S et al (2014) Globus pallidus deep brain stimulation for adult-onset axial dystonia. Parkinsonism Relat Disord 20(11):1279\u20131282","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"9119_CR75","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s00415-013-7161-2","volume":"261","author":"M Jahanshahi","year":"2014","unstructured":"Jahanshahi M, Torkamani M, Beigi M, Wilkinson L, Page D, Madeley L et al (2014) Pallidal stimulation for primary generalised dystonia: effect on cognition, mood and quality of life. J Neurol 261(1):164\u2013173","journal-title":"J Neurol"},{"issue":"3","key":"9119_CR76","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1474-4422(07)70035-2","volume":"6","author":"M Vidailhet","year":"2007","unstructured":"Vidailhet M, Vercueil L, Houeto J-L, Krystkowiak P, Lagrange C, Yelnik J et al (2007) Bilateral, pallidal, deep-brain stimulation in primary generalised dystonia: a prospective 3 year follow-up study. Lancet Neurol 6(3):223\u2013229","journal-title":"Lancet Neurol"},{"issue":"13","key":"9119_CR77","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/mds.25586","volume":"28","author":"C Cao","year":"2013","unstructured":"Cao C, Pan Y, Li D, Zhan S, Zhang J, Sun B (2013) Subthalamus deep brain stimulation for primary dystonia patients: a long-term follow-up study. Mov Disord 28(13):1877\u20131882","journal-title":"Mov Disord"},{"issue":"6","key":"9119_CR78","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2165\/00019053-199712060-00007","volume":"12","author":"CM Gudex","year":"1997","unstructured":"Gudex CM, Hawthorne MR, Butler AG, Duffey PO (1997) Measuring patient benefit from botulinum toxin in the treatment of dystonia. Feasibility of cost-utility analysis. Pharmacoeconomics 12(6):675\u2013684","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"9119_CR79","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00002826-200007000-00006","volume":"23","author":"C Brefel-Courbon","year":"2000","unstructured":"Brefel-Courbon C, Simonetta-Moreau M, More C, Rascol O, Clanet M, Montastruc JL et al (2000) A pharmacoeconomic evaluation of botulinum toxin in the treatment of spasmodic torticollis. Clin Neuropharmacol 23(4):203\u2013207","journal-title":"Clin Neuropharmacol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-9119-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-018-9119-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-9119-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T14:42:02Z","timestamp":1662475322000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-018-9119-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,20]]},"references-count":79,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["9119"],"URL":"https:\/\/doi.org\/10.1007\/s00415-018-9119-x","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,20]]},"assertion":[{"value":"26 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The article is based upon previously published studies and patient data and is in line with the journal\u2019s ethical guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}